In a nutshell This trial is examining the effectiveness of alternating doses of SAR341402 and insulin aspart (Novolog) compared with a continuous dose of insulin aspart in patients with type 1 diabetes (T1D). The main outcomes to be measured will be the similarity between the two drugs and side effects. This trial is...
Read MoreInsulin medication(s)-Novolog (Aspart) Posts on Medivizor
How safe and effective is fast-acting insulin aspart in a continuous insulin infusion in type 1 diabetes?
In a nutshell The aim of this study was to investigate how safe and effective fast-acting insulin aspart (faster aspart) is compared to insulin aspart (NovoRapid, NovoLog) when used in a continuous insulin pump in type 1 diabetes (T1D). The main finding was that faster aspart is a safe and effective option in a continuous insulin pump for these...
Read MoreContinuous glucose monitoring improves glycemic control in patients with type 1 diabetes
In a nutshell This study investigated the effect of continuous glucose monitoring (CGM) in managing blood sugar levels in patients with type 1 diabetes treated with multiple daily insulin injections. They found CGM resulted in a clinically meaningful improvement in glycemic (blood sugar) control. Some background Glycemic control is critical for...
Read MorePump it up – does diluting insulin aspart quicken its action in type 1 diabetes?
In a nutshell This study investigated the effect of diluting insulin aspart (B28Asp human insulin) in children aged 3-6 with type 1 diabetes. Some background Insulin is typically the first treatment for type 1 diabetes patients. One of the methods of delivery is via an insulin pump. In closed-loop insulin delivery, blood glucose is...
Read More
